title: Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
abstract: Oncolytic viruses kill cancer cells by tumor-selective replication. Clinical data have established the safety of the approach but also the need of improvements in potency. Efficacy of oncolysis is linked to effective infection of target cells and subsequent productive replication. Other variables include intratumoral barriers, access to target cells, uptake by non-target organs and immune response. Each of these aspects relates to the location and degree of virus replication. Unfortunately, detection of in vivo replication has been difficult, labor intensive and costly and therefore not much studied. We hypothesized that by coinfection of a luciferase expressing E1-deleted virus with an oncolytic virus, both viruses would replicate when present in the same cell. Photon emission due to conversion of D-Luciferin is sensitive and penetrates tissues well. Importantly, killing of animals is not required and each animal can be imaged repeatedly. Two different murine xenograft models were used and intratumoral coinjections of luciferase encoding virus were performed with eight different oncolytic adenoviruses. In both models, we found significant correlation between photon emission and infectious virus production. This suggests that the system can be used for non-invasive quantitation of the amplitude, persistence and dynamics of oncolytic virus replication in vivo, which could be helpful for the development of more effective and safe agents.
authors: Cancer Gene Therapy Group, Molecular Cancer Biology Program and Haartman Institute, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
authors: K
authors: K
authors: Guse
authors: J D
authors: JD
authors: Dias
authors: G J
authors: GJ
authors: Bauerschmitz
authors: T
authors: T
authors: Hakkarainen
authors: E
authors: E
authors: Aavik
authors: T
authors: T
authors: Ranki
authors: T
authors: T
authors: Pisto
authors: M
authors: M
authors: Särkioja
authors: R A
authors: RA
authors: Desmond
authors: A
authors: A
authors: Kanerva
authors: A
authors: A
authors: Hemminki
mesh_terms: D000256:Adenoviridae / Q000235:genetics* / Q000502:physiology; D000818:Animals; D005260:Female; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage; D007091:Image Processing, Computer-Assisted; D007274:Injections, Intraperitoneal; D008156:Luciferases / Q000032:analysis* / Q000235:genetics; D051379:Mice; D008819:Mice, Nude; D036641:Microscopy, Fluorescence, Multiphoton; D023421:Models, Animal; D009369:Neoplasms / Q000473:pathology / Q000628:therapy*; D050130:Oncolytic Virotherapy / Q000379:methods; D050504:Oncolytic Viruses / Q000235:genetics* / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014161:Transduction, Genetic / Q000379:methods; D014779:Virus Replication
chemical_list: D008156:Luciferases